Regulation 202 Amendment of regulation 259 (packaging requirements: information for blind and partially sighted patients)I1
United Kingdom
In regulation 259(2), F1for “marketing authorisation,” substitute “UK marketing authorisation, EU marketing authorisation”.
Annotations
Textual amendments
- F1
Words in reg. 202 substituted (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 156
Commencement
- I1
Reg. 202 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1